Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • Bitcoin USD

    63,616.51
    -1,063.10 (-1.64%)
     
  • CMC Crypto 200

    1,325.91
    -70.62 (-5.06%)
     
  • S&P 500

    5,112.29
    +63.87 (+1.27%)
     
  • Dow

    38,317.68
    +231.88 (+0.61%)
     
  • Nasdaq

    15,969.09
    +357.33 (+2.29%)
     
  • Gold

    2,344.90
    +2.40 (+0.10%)
     
  • Crude Oil

    83.83
    +0.26 (+0.31%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Microchip (MCHP) Q3 Earnings Top Estimates, Sales Rise Y/Y

Microchip Technology MCHP reported third-quarter fiscal 2023 non-GAAP earnings of $1.56 per share, which beat the Zacks Consensus Estimate by 0.65% and rose 30% on a year-over-year basis.

Net sales of $2.17 billion increased 31.5% year over year and surpassed the Zacks Consensus Estimate by 0.89%.

Although strong microcontroller sales benefited top-line growth, Microchip suffered from a weak China market due to disruption caused by COVID-19. The company witnessed slowing bookings in the reported quarter.

Quarter in Detail

In terms of product line, microcontroller sales grew 25.6% year over year and 3.5% sequentially to $1.22 billion, accounting for 56.3% of revenues.

Analog net sales of $606.5 million increased 5.9% sequentially and 21.2% year over year. Analog contributed 28% to the total revenues.

Microchip Technology Incorporated Price, Consensus and EPS Surprise

 

Microchip Technology Incorporated Price, Consensus and EPS Surprise
Microchip Technology Incorporated Price, Consensus and EPS Surprise

Microchip Technology Incorporated price-consensus-eps-surprise-chart | Microchip Technology Incorporated Quote

ADVERTISEMENT

Other revenues of $341.4 million accounted for 15.7% of revenues.

Geographically, revenues from the Americas, Europe and Asia contributed 26.2%, 19.8% and 54.1% to net sales, respectively.

The non-GAAP gross margin contracted 230 basis points (bps) on a year-over-year basis to 68.1%.

Non-GAAP research and development expenses, as a percentage of net sales, declined 140 bps year over year to 12%. Non-GAAP selling, general and administrative expenses, as a percentage of net sales, declined 80 bps to 8.6%.

Non-GAAP operating expenses, as a percentage of net sales, declined 220 bps year over year to 20.6%.

Consequently, the non-GAAP operating margin contracted 10 bps on a year-over-year basis to 47.5%.

Balance Sheet & Cash Flow

As of Dec 31, 2022, cash and short-term investments totaled $288.9 million compared with $306.8 million as of Sep 30, 2022.

As of Dec 31, 2022, its total debt (long-term plus current portion) was $6.59 billion. The company paid down $719.1 million of debt in the reported quarter.

For the fiscal third quarter, cash flow from operating activities was $1.28 billion compared with $793.2 million in the previous quarter.

Free cash flow was $1.14 billion compared with $682.9 million in the previous quarter.

Microchip returned $409.8 million to shareholders in the fiscal third quarter through dividends of $180.3 million and share repurchases of $229.5 million.

Microchip announced a quarterly dividend of 35.8 cents per share, up 9.1% sequentially and 41.5% from the year-ago quarter.

Guidance

Microchip expects net sales of $2.191-$2.256 billion for fourth-quarter fiscal 2023, indicating 1-4% sequential growth. At the mid-point of the guidance, net sales are expected to grow 20.6% year over year.

Non-GAAP earnings are anticipated between $1.61 per share and $1.63 per share.

The non-GAAP gross margin is anticipated between 68.1% and 68.3%.

Non-GAAP operating expenses are projected to be 20.6-20.8%.

The non-GAAP operating margin is anticipated to be 47.3-47.7%.

Capital expenditure for the fiscal fourth quarter is expected between $154 million and $174 million. Capital expenditure for fiscal 2023 is estimated between $525 million and $545 million.

Zacks Rank & Stocks to Consider

Microchip currently carries a Zacks Rank #4 (Sell).

Cambium Networks CMBM, Bruker BRKR and RingCentral RNG are some better-ranked stocks that investors can consider in the broader sector. While Cambium currently sports a Zacks Rank #1 (Strong Buy), both Bruker and RingCentral carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Cambium shares have declined 9.9% in the past year. CMBM is set to report its fourth-quarter 2022 results on Feb 16.

Bruker shares have gained 8.2% in the past year. BRKR is set to report its fourth-quarter 2022 results on Feb 9.

RingCentral shares have declined 70.4% in the past year. RNG is set to report its fourth-quarter 2022 results on Feb 15.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Microchip Technology Incorporated (MCHP) : Free Stock Analysis Report

Bruker Corporation (BRKR) : Free Stock Analysis Report

Ringcentral, Inc. (RNG) : Free Stock Analysis Report

Cambium Networks Corporation (CMBM) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research